Creative Medical Technology Holdings Inc (CELZ)

[devilfromscratch]

Creative Medical Technology Holdings Inc (OTCMKTS: CELZ) is Doing What Most Biotechs Have Not
By Gene Daniel - April 9, 2018
FacebookTwitter
Creative Medical Technology Holdings Inc (OTCMKTS:CELZ) has been seeing a fervor of investor interest recently. CELZ saw more than 200M shares swapped in one day last week. Over the last month, CELZ is seeing a price change of over 150% but the stock overall is on a bear run when you step back for a moment. Over the last six months, the stock has shed half its value, so what has changed recently?

CELZ has two powerful things working for it: it is nearing commercialization and has cleared bad debt from its books. Investors are jumping in as it is quite difficult to do this in the biotech world. In addition, CELZ has already begun marketing its lead CaverStem stem cell procedure for erectile dysfunction in California. Plans are also underway to unveil the procedure at the upcoming American Urological Association conference in May, as part of an effort that seeks to broaden awareness to more clients and users:



“Our cutting-edge technology in autologous stem cell treatment for erectile dysfunction is anticipated to be received by the urologic community with great enthusiasm. Our CaverStem TM procedure represents an all-natural alternative for those patients resistant to the use of PDE5 inhibitors such as Viagra and Cialis,” said Thomas Ichim PhD, Founder and Chief Scientific Officer of CELZ.